免疫測定法の市場規模、シェア、成長分析：製品別、技術別、検体別、用途別、エンドユーザー別、地域別 - 産業予測 2025～2032年

免疫測定法市場規模は2023年に358億米ドルとなり、予測期間（2025～2032年）のCAGRは6.3%で、2024年の380億6,000万米ドルから2032年には620億4,000万米ドルに成長する見通しです。

世界の免疫測定法市場は、技術の進歩、診断検査に対する需要の高まり、臨床診断、環境検査、バイオ医薬品などの多様なアプリケーションに牽引され、力強い成長を遂げています。この成長は、アッセイのばらつきや新規イムノアッセイの開発に伴う複雑さやコストといった課題によって抑制されています。技術革新には多額の投資が不可欠であり、これが市場参入の障壁となっています。しかし、個別化医療へのトレンドの高まりがイムノアッセイの利用を後押ししているほか、官民双方からの研究助成金も増加していることから、市場参入のチャンスも生まれつつあります。全体として、市場は一定のハードルに直面しているものの、特に進化するヘルスケアニーズと市場力学に対応するため、市場拡大の可能性は依然として高いです。

目次

イントロダクション

• 調査の目的
• 調査範囲
• 定義

調査手法

• 情報調達
• 二次と一次データの方法
• 市場規模予測
• 市場の前提条件と制限

エグゼクティブサマリー

• 世界市場の見通し
• 供給と需要の動向分析
• セグメント別機会分析

市場力学と見通し

• 市場概要
• 市場規模
• 市場力学
  • 促進要因と機会
  • 抑制要因と課題
• ポーターの分析

主な市場の考察

• 重要成功要因
• 競合の程度
• 主な投資機会
• 市場エコシステム
• 市場の魅力指数（2024年）
• PESTEL分析
• マクロ経済指標
• バリューチェーン分析
• 価格分析
• 規制分析
• 技術分析
• 特許分析

免疫測定法市場規模：製品別

• 市場概要
• 試薬とキット
  • ELISA試薬とキット
  • CLIA試薬とキット
  • IFA試薬とキット
  • 迅速検査試薬とキット
  • ELISpot試薬とキット
  • ウェスタンブロット試薬とキット
  • その他の試薬とキット
• アナライザー
  • タイプ別
  • オープンエンドシステム
  • クローズドエンドシステム
  • 購入モード別
  • レンタル購入
  • 完全購入

免疫測定法市場規模：技術別

• 市場概要
• ELISA
• 化学発光免疫測定法（CLIA）
• 免疫蛍光アッセイ（IFA）
• 迅速検査
• エリスポット
• ウェスタンブロッティング
• その他の技術

免疫測定法市場規模：検体別

• 市場概要
• 血
• 唾液
• 尿
• その他の標本

免疫測定法市場規模：用途別

• 市場概要
• 感染症
• 内分泌学
• 腫瘍学
• 骨およびミネラル疾患
• 心臓病学
• 血液検査
• 自己免疫疾患
• アレルギー診断
• 毒物学
• 新生児スクリーニング
• その他の用途

免疫測定法市場規模：エンドユーザー別

• 市場概要
• 病院と診療所
• 臨床検査室
• 製薬・バイオテクノロジー企業およびCRO
• 血液銀行
• 調査・学術研究所
• 在宅ケア設定

免疫測定法市場規模

• 北米
  • 米国
  • カナダ
• 欧州
  • ドイツ
  • スペイン
  • フランス
  • 英国
  • イタリア
  • その他欧州地域
• アジア太平洋地域
  • 中国
  • インド
  • 日本
  • 韓国
  • その他アジア太平洋地域
• ラテンアメリカ
  • ブラジル
  • その他ラテンアメリカ地域
• 中東・アフリカ
  • GCC諸国
  • 南アフリカ
  • その他中東・アフリカ

競合情報

• 上位5社の比較
• 主要企業の市場ポジショニング（2024年）
• 主な市場企業が採用した戦略
• 最近の市場動向
• 企業の市場シェア分析（2024年）
• 主要企業の企業プロファイル
  • 企業の詳細
  • 製品ポートフォリオ分析
  • 企業のセグメント別シェア分析
  • 収益の前年比比較（2022～2024年）

主要企業プロファイル

• Abbott Laboratories（USA）
• F. Hoffmann-La Roche AG（Switzerland）
• Thermo Fisher Scientific Inc.（USA）
• Siemens Healthineers AG（Germany）
• Danaher Corporation（USA）
• Becton, Dickinson and Company（BD）（USA）
• Bio-Rad Laboratories, Inc.（USA）
• QIAGEN N.V.（Germany/Netherlands）
• Sysmex Corporation（Japan）
• Merck KGaA（Germany）
• DiaSorin S.p.A.（Italy）
• bioMerieux SA（France）
• QuidelOrtho Corporation（USA）
• Agilent Technologies, Inc.（USA）
• Hologic Inc.（USA）
• PerkinElmer, Inc.（USA）
• Luminex Corporation（USA）
• Autobio Diagnostics Co., Ltd.（China）
• Beckman Coulter, Inc.（USA）
• Randox Laboratories（UK）

結論と提言

Immunoassay Market size was valued at USD 35.8 billion in 2023 and is poised to grow from USD 38.06 billion in 2024 to USD 62.04 billion by 2032, growing at a CAGR of 6.3% during the forecast period (2025-2032).

The global immunoassay market is experiencing robust growth, driven by technological advancements, heightened demand for diagnostic testing, and diverse applications in clinical diagnostics, environmental testing, and biopharmaceuticals. This growth is tempered by challenges such as assay variability and the complexities and costs associated with developing novel immunoassays. Significant investments are essential for innovation, which can create barriers to market entry. However, opportunities are emerging, particularly with the increasing trend toward personalized medicine that boosts the usage of immunoassays, along with rising funding from both private and public sectors for research initiatives. Overall, while the market faces certain hurdles, the potential for expansion remains strong, particularly in response to evolving healthcare needs and market dynamics.

Top-down and bottom-up approaches were used to estimate and validate the size of the Immunoassay market and to estimate the size of various other dependent submarkets. The research methodology used to estimate the market size includes the following details: The key players in the market were identified through secondary research, and their market shares in the respective regions were determined through primary and secondary research. This entire procedure includes the study of the annual and financial reports of the top market players and extensive interviews for key insights from industry leaders such as CEOs, VPs, directors, and marketing executives. All percentage shares split, and breakdowns were determined using secondary sources and verified through Primary sources. All possible parameters that affect the markets covered in this research study have been accounted for, viewed in extensive detail, verified through primary research, and analyzed to get the final quantitative and qualitative data.

Immunoassay Market Segments Analysis

Global Immunoassay Market is segmented by Product, Technology, Specimen, Application, End User and region. Based on Product, the market is segmented into Reagents & Kits and Analyzers. Based on Technology, the market is segmented into ELISA, Chemiluminescence Immunoassay (CLIA), Immunofluorescence assay (IFA), Rapid Tests, ELISpot, Western Blotting and Other Technologies. Based on Specimen, the market is segmented into Blood, Saliva, Urine and Other Specimens. Based on Application, the market is segmented into Infectious Diseases, Endocrinology,Oncology, Bone & Mineral Disorders, Cardiology, Blood Screening, Autoimmune Disorders, Allergy Diagnostics, Toxicology, Newborn Screening and Other Applications. Based on End User, the market is segmented into Hospitals & Clinics, Clinical Laboratories, Pharmaceutical & Biotechnology Companies and CROs, Blood Banks, Research & Academic Laboratories and Home Care Settings. Based on region, the market is segmented into North America, Europe, Asia Pacific, Latin America and Middle East & Africa.

Driver of the Immunoassay Market

The immunoassay market is being significantly propelled by increased funding from both governmental bodies and organizations aimed at advancing healthcare research and development. This surge in financial support is fostering the creation and enhancement of advanced immunoassay technologies. Additionally, heightened investments from the private sector, particularly in therapeutic and diagnostic research, are further stimulating demand and innovation within the immunoassay field. As a result, the combination of private sector contributions and proactive government initiatives plays a crucial role in driving the growth and evolution of the immunoassay market.

Restraints in the Immunoassay Market

The immunoassay market faces significant constraints in certain developing regions due to inadequate healthcare infrastructure and a lack of awareness regarding immunoassay techniques. This limited understanding hampers the market's growth potential, as there is an increasing need for education and training on these methodologies, which can be both challenging and costly to implement. Additionally, the shortage of skilled professionals capable of interpreting results and effectively operating immunoassay systems further limits the adoption and demand for these technologies. Consequently, these factors collectively impede the overall expansion of the immunoassay market in these areas.

Market Trends of the Immunoassay Market

The immunoassay market is witnessing significant growth, driven by the expanding applications across various sectors. With the increasing prevalence of infectious and chronic diseases, there is a heightened demand for immunoassays for effective disease monitoring and detection. The biopharmaceutical industry particularly fuels this trend, as these assays are essential for therapeutic monitoring and drug development. Additionally, the rising focus on environmental safety has led to a growing need for immunoassays to detect contaminants, further broadening their application scope. As a result, the market is poised for robust growth, reflecting the versatility and critical role of immunoassays in healthcare and environmental contexts.

Table of Contents

Introduction

• Objectives of the Study
• Scope of the Report
• Definitions

Research Methodology

• Information Procurement
• Secondary & Primary Data Methods
• Market Size Estimation
• Market Assumptions & Limitations

Executive Summary

• Global Market Outlook
• Supply & Demand Trend Analysis
• Segmental Opportunity Analysis

Market Dynamics & Outlook

• Market Overview
• Market Size
• Market Dynamics
  • Drivers & Opportunities
  • Restraints & Challenges
• Porters Analysis
  • Competitive rivalry
  • Threat of substitute
  • Bargaining power of buyers
  • Threat of new entrants
  • Bargaining power of suppliers

Key Market Insights

• Key Success Factors
• Degree of Competition
• Top Investment Pockets
• Market Ecosystem
• Market Attractiveness Index, 2024
• PESTEL Analysis
• Macro-Economic Indicators
• Value Chain Analysis
• Pricing Analysis
• Regulatory Analysis
• Technology Analysis
• Patent Analysis

Global Immunoassay Market Size by Product & CAGR (2025-2032)

• Market Overview
• Reagents & Kits
  • ELISA Reagents & Kits
  • CLIA Reagents & Kits
  • IFA Reagents & Kits
  • Rapid Test Reagent & Kits
  • ELISpot Reagent & Kits
  • Western Blot Reagent & Kits
  • Other Reagents & Kits
• Analyzers
  • By Type
  • Open-ended Systems
  • Closed-ended Systems
  • By Purchase Mode
  • Rental Purchase
  • Outright Purchase

Global Immunoassay Market Size by Technology & CAGR (2025-2032)

• Market Overview
• ELISA
• Chemiluminescence Immunoassay (CLIA)
• Immunofluorescence assay (IFA)
• Rapid Tests
• ELISpot
• Western Blotting
• Other Technologies

Global Immunoassay Market Size by Specimen & CAGR (2025-2032)

• Market Overview
• Blood
• Saliva
• Urine
• Other Specimens

Global Immunoassay Market Size by Application & CAGR (2025-2032)

• Market Overview
• Infectious Diseases
• Endocrinology
• Oncology
• Bone & Mineral Disorders
• Cardiology
• Blood Screening
• Autoimmune Disorders
• Allergy Diagnostics
• Toxicology
• Newborn Screening
• Other Applications

Global Immunoassay Market Size by End User & CAGR (2025-2032)

• Market Overview
• Hospitals & Clinics
• Clinical Laboratories
• Pharmaceutical & Biotechnology Companies and CROs
• Blood Banks
• Research & Academic Laboratories
• Home Care Settings

Global Immunoassay Market Size & CAGR (2025-2032)

• North America (Product, Technology, Specimen, Application, End User)
  • US
  • Canada
• Europe (Product, Technology, Specimen, Application, End User)
  • Germany
  • Spain
  • France
  • UK
  • Italy
  • Rest of Europe
• Asia Pacific (Product, Technology, Specimen, Application, End User)
  • China
  • India
  • Japan
  • South Korea
  • Rest of Asia-Pacific
• Latin America (Product, Technology, Specimen, Application, End User)
  • Brazil
  • Rest of Latin America
• Middle East & Africa (Product, Technology, Specimen, Application, End User)
  • GCC Countries
  • South Africa
  • Rest of Middle East & Africa

Competitive Intelligence

• Top 5 Player Comparison
• Market Positioning of Key Players, 2024
• Strategies Adopted by Key Market Players
• Recent Developments in the Market
• Company Market Share Analysis, 2024
• Company Profiles of All Key Players
  • Company Details
  • Product Portfolio Analysis
  • Company's Segmental Share Analysis
  • Revenue Y-O-Y Comparison (2022-2024)

Key Company Profiles

• Abbott Laboratories (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• F. Hoffmann-La Roche AG (Switzerland)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Thermo Fisher Scientific Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Siemens Healthineers AG (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Danaher Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Becton, Dickinson and Company (BD) (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Bio-Rad Laboratories, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QIAGEN N.V. (Germany/Netherlands)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Sysmex Corporation (Japan)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Merck KGaA (Germany)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• DiaSorin S.p.A. (Italy)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• bioMerieux SA (France)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• QuidelOrtho Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Agilent Technologies, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Hologic Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• PerkinElmer, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Luminex Corporation (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Autobio Diagnostics Co., Ltd. (China)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Beckman Coulter, Inc. (USA)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments
• Randox Laboratories (UK)
  • Company Overview
  • Business Segment Overview
  • Financial Updates
  • Key Developments

Conclusion & Recommendations